Efficacy of melatonin to normalize the cytokines network and balance the oxidative stress in methamphetamine-induced psychosis patients: a double-blinded randomized controlled trial.

Chulalongkorn University0 个研究点目标入组 64 人开始时间: 2024年5月29日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Participants are newly admitted to PMNIDAT and diagnosed with methamphetamine-induced psychosis.
•2. Participants can have history of ultilization of alcohol and nicotine but methamphetamine must be the primary cause of psychosis.
•3. Agree to take part in the study.

•1. History of primary psychiatric disorders such as primary psychosis disorders, mood disorders, anxiety disorders, mild and major neurocognitive disorders.
•2. History of autoimmune disorders and allergy to melatonin.
•3. Currently have any allergic, infectious/inflammatory diseases, or have any signs or symptoms suggesting an allergic/infectious/inflammatory condition.
•4. Currently receive any other treatments than the study experimental treatment.
•5. Used other substance than methamphetamine, alcohol and nicotine in the last 1 month.
•6. Female participants who currently get pregnant or practice breastfeeding.

发起方